Provided by Tiger Fintech (Singapore) Pte. Ltd.

Summit Therapeutics PLC

26.34
+0.14000.53%
Post-market: 26.650.3100+1.18%17:04 EDT
Volume:1.92M
Turnover:50.99M
Market Cap:19.56B
PE:-77.57
High:27.25
Open:26.51
Low:26.23
Close:26.20
Loading ...
Nov 13, 2020

Major Issues Report

8-K - Current report
Nov 10, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 10, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 06, 2020

Major Issues Report

8-K - Current report
Oct 13, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 07, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Oct 05, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Oct 05, 2020

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Oct 05, 2020

Major Issues Report

8-K - Current report
Sep 29, 2020

Major Issues Report

8-K - Current report
Sep 29, 2020

Major Issues Report

8-K - Current report
Sep 28, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Sep 28, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Sep 18, 2020

Delisting

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Jun 17, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 21, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 15, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Apr 30, 2020

Annual Report

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 26, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Feb 26, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]